An idea of whats at stake in trials with Merck etcMerck agrees $1 billion deal with Debiopharm for head and neck cancer drughttps://www.reuters.com/article/us-debiopharm-merck-idUSKCN2AT2EK
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
